Risk Factors Associated with Bleeding After Alteplase Administration for Pulmonary Embolism: A Case-Control Study-Reference-Cited by-同舟云学术

Risk Factors Associated with Bleeding After Alteplase Administration for Pulmonary Embolism: A Case-Control Study

Published:2014-05-22 Issue:8 Volume:34 Page:818-825
ISSN:0277-0008
Container-title:Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
language:en
Short-container-title:Pharmacotherapy

Author:

Curtis Garrett M.¹,Lam Simon W.²,Reddy Anita J.³,Bauer Seth R.²

Affiliation:

1. Department of Pharmacy; University of Alabama at Birmingham Hospital; Birmingham Alabama

2. Department of Pharmacy; Cleveland Clinic; Cleveland Ohio

3. Respiratory Institute; Cleveland Clinic; Cleveland Ohio

Funder

Cleveland Clinic Department of Pharmacy

Publisher

Wiley

Subject

Pharmacology (medical)

Link

Reference27 articles.

1. Heart disease and stroke statistics-2013 update: a report from the American Heart Association;Go;Circulation,2013

4. Thrombolytic therapy for pulmonary embolism;Dong;Cochrane Database Syst Rev,2009

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

3. Pulmonary Embolism Complicated by Active Bleeding;PERT Consortium Handbook of Pulmonary Embolism ;2023